Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
Atopic dermatitis is an inflammatory skin disease characterized by significant permeability barrier damage. Regulation and maintenance of permeability and antimicrobial skin barriers are strongly connected. There is a lack of comprehensive studies of the expression of all 5 major antimicrobial pepti...
Saved in:
Main Authors: | Lilla Szabó (Author), Anikó Kapitány (Author), Orsolya Somogyi (Author), Iman Alhafez (Author), Krisztián Gáspár (Author), Réka Palatka (Author), Lilla Soltész (Author), Dániel Törőcsik (Author), Zoltán Hendrik (Author), Zsolt Dajnoki (Author), Andrea Szegedi (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Immune and Barrier Characteristics in Scalp and Skin Psoriasis
by: Krisztián Gáspár, et al.
Published: (2020) -
Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021) -
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021) -
Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
by: Young Ji Hwang, et al.
Published: (2014) -
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022)